GE to Invest in Israeli Company That Developed Swallowable Endoscopic Capsules
The capsule differs from competitor Given Imaging's PillCam because it uses low-energy X-rays instead of light. This produces a different image and could eliminate the need for typical GI tract preparation because X-rays penetrate through soft material like food. The technology could be used to screen for colorectal cancer as well as other diseases of the GI tract.
Check-Cap plans to introduce the technology in Europe before the end of 2013 and is currently in talks with the FDA.
Related Articles on Gastroenterology:
Colorectal Cancer Screening Rates by the Numbers: 12 Recent Statistics
Study: Demand for Screening Colonoscopy Down During Recession
Global Endoscopy Market Expected to Grow 13.2% in Next Three Years
© Copyright ASC COMMUNICATIONS 2016. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- URMC to participate in ACGME quality & patient safety initiative: 5 takeaways
- Cigna serves as a beacon of hope for the ACA, expands into new markets: 4 things to know
- 6 key considerations before diving into bundled payments — Take it from a frontrunner ASC
- Inconsistencies among medical examiners skew firearm-related death data: 5 takeaways
- Total joint replacement in ASCs: 10 years & counting for Pacific Rim Outpatient Surgery Center — 5 things to know